ArticleCell2018

Multi-level Proteomics Identifies CT45 as a Chemosensitivity Mediator and Immunotherapy Target in Ovarian Cancer.

Fabian Coscia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.